Literature DB >> 52848

Carcinogenesis.

M Calvin.   

Abstract

An examination has been made of the major chemicals which are known to be carcinogenic, either in animals or in humans. As a result, a generalized type of chemical property seems to be a prerequisite for the carcinogenic activity. In most cases, this is some kind of reactive electrophilic intermediate produced directly from the carcinogen or from one of its immediate metabolites. This electrophilic reagent is generally a positively charged ion of some kind. In the case of the hydrocarbons it seems to be an incipient carbonium ion; in the case of nitrogen compounds, it is a corresponding nitronium ion. There are a number of possible substrate materials (nucleophilic) in a cells, but the dominant one which has been suspected is the nucleic acid component, either the DNA or the RNA. The bases of these materials all have extra pi electrons susceptible to attach by the electrophiles of the carcinogen. Such a modification, particularly of the DNA, could lead to either major or minor changes in the genetic composition of the cell. Minor changes are usually rectifiable or are not visible, and this would include a large variety of point mutations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52848     DOI: 10.1007/bf00612091

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  31 in total

1.  Epoxides as microsomal metabolites of polycyclic hydrocarbons.

Authors:  P L. Grover; A Hewer; P Sims
Journal:  FEBS Lett       Date:  1971-10-15       Impact factor: 4.124

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  Inhibition of three nucleotide polymerases by rifamycin derivatives.

Authors:  F M Thompson; A N Tischler; J Adams; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

5.  Microsomal hydroxylases: induction and role in polycyclic hydrocarbon carcinogenesis and toxicity.

Authors:  H V Gelboin; N Kinoshita; F J Wiebel
Journal:  Fed Proc       Date:  1972 Jul-Aug

Review 6.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture.

Authors:  J A Miller
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

7.  Photochemical coupling of benzo(a)pyrene with 1-methylcytosine; photoenhancement of carcinogenicity.

Authors:  E Cavalieri; M Calvin
Journal:  Photochem Photobiol       Date:  1971-11       Impact factor: 3.421

8.  Effect of dimethylbenzyldesmethylrifampicin (DMB) on chemically induced mammary tumours in rats.

Authors:  U R Joss; A M Hughes; M Calvin
Journal:  Nat New Biol       Date:  1973-03-21

9.  Effect of rifampicin and two of its derivatives on cells infected with Moloney sarcoma virus.

Authors:  M Calvin; U R Joss; A J Hackett; R B Owens
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Preferential inhibition of the growth of virus-transformed cells in culture by rifazone-82, a new rifamycin derivative.

Authors:  M J Bissell; C Hatie; A N Tischler; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

View more
  3 in total

1.  Is the product of the src gene a promoter?

Authors:  M J Bissell; C Hatié; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  Bistability in fluctuating environments. Implications in tumor immunology.

Authors:  R Lefever; W Horsthemke
Journal:  Bull Math Biol       Date:  1979       Impact factor: 1.758

3.  Changes in mouse skin cyclic nucleotides during chemical carcinogenesis and tumor response to treatment with BCG, L-Dopa and cyclic DBAMP.

Authors:  E Busse; H Rose; K H Riessbeck
Journal:  J Cancer Res Clin Oncol       Date:  1979-06-08       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.